(Q69768800)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2801750%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

title

Simvastatin: the clinical profile (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2801750%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

1 reference

J F Walker

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2801750%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

publication date

1 October 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2801750%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Medicine

5 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2801750%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

volume

87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2801750%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

issue

4A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2801750%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

page(s)

44S-46S

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2801750%20AND%20SRC:MED&resulttype=core&format=json

New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase

5 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980598-4

Cholesterol-lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase, in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980598-4

Effects of synvinolin (MK-733) on plasma lipids in familial hypercholesterolaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980598-4

EFFECTS OF TRIPARANOL (MER-29) ON CHOLESTEROL BIOSYNTHESIS AND ON BLOOD STEROL LEVELS IN MAN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980598-4

A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980598-4

Simvastatin, a competitive inhibitor of HMG-CoA reductase, lowers cholesterol saturation index of gallbladder bile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980598-4

HMG-CoA reductase inhibitors for treatment of hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980598-4

Myolysis and acute renal failure in a heart-transplant recipient receiving lovastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980598-4

Preliminary report: treatment of type 3 hyperlipoproteinemia with mevinolin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980598-4

Rhabdomyolysis in patients receiving lovastatin after cardiac transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980598-4

10.1016/S0002-9343(89)80598-4

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2801750%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

1 reference